Stay informed with the latest updates for the inheritable blood disorders community. Industry Investigational Data on VWD and Glanzmann Thrombasthenia…Jul 2, 2025 Industry Trial Data for Roche Investigational SubQ Hemophilia Therapy Presented…Jun 26, 2025 Medical New Accredited Activity Explores Individualized Care for von…Jun 20, 2025 Medical FDA Approved Test Measures Concizumab-mtci in Hemophilia PatientsJun 18, 2025 Industry Integration of Spark into Roche Group Set, Hemophilia Gene…Jun 9, 2025 Medical FDA Grants Jivi Expanded FDA Indication for Younger Hemophilia A Patients…May 22, 2025 Medical NEJM Publishes Follow-up Data on Hemophilia B Gene Therapy ProductMay 16, 2025 Medical FDA Approves Qfitlia: New Hemophilia Therapy BreakthroughApr 3, 2025 Industry First Patient Dosed with Investigational Sub-Q Therapy for von…Mar 5, 2025 Industry Pfizer Discontinues Beqvez Hemophilia B Gene TherapyFeb 25, 2025 Medical FDA Approves New Non-Opioid Treatment for Pain Jan 31, 2025 Medical Clinical Practice and Hemophilia Gene Therapy the Focus of New…Jan 13, 2025 Industry Investigational Sub-Q Von Willebrand Disease Therapy Put on Fast TrackJan 10, 2025 Medical FDA Approves Subcutaneous Therapy for Hemophilia Patients with Inhibitors…Dec 23, 2024 Industry Trial Updates for Investigational Hemophilia A Gene Therapy Shared at ASH…Dec 13, 2024 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page